Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of American Physicians Capital, Inc. (“AP Capital” or the “Company”) (NasdqGS: ACAP) concerning the Company’s entry into a definitive agreement with The Doctors Company through which The Doctors Company will acquire AP Capital for $41.50 per share in cash, or an aggregate purchase price of approximately $386 million.

The investigation is focused on the potential unfairness of the price for AP Capital shareholders and the process by which the AP Capital Board of Directors shopped the Company and considered the transaction.

If you are interested in discussing your rights as an AP Capital shareholder, or have information relating to this investigation, please contact Finkelstein Thompson's Washington, DC offices at (877) 337-1050 or by email at

Finkelstein Thompson LLP has spent over three decades delivering outstanding representation to institutional and individual clients in financial litigation, and has been appointed as lead or co-lead counsel in dozens of shareholder class actions. Indeed, the firm has served in leadership roles in cases that have recovered over $1 billion for investors and consumers.

To learn more about Finkelstein Thompson LLP, please visit our web site at Attorney advertising. Prior results do not guarantee similar outcomes.

Copyright Business Wire 2010